Lidocaine Spray for Nasogastric Tube Insertion
Yes, 2% lidocaine spray is appropriate and recommended for nasogastric tube insertion to provide local anesthesia, as it significantly reduces patient pain and discomfort without increasing complications.
Evidence Supporting Lidocaine Use
The evidence strongly supports topical lidocaine application before NG tube insertion:
A systematic review and meta-analysis of 10 RCTs (734 patients) demonstrated that lidocaine reduced pain scores by 26% (mean difference -26.05,95% CI -28.21 to -23.89, p<0.001) without increasing nasal bleeding or vomiting 1.
Multiple randomized controlled trials consistently show that lidocaine spray plus lidocaine jelly lubrication is superior to jelly alone, with patients experiencing significantly less pain (23.6 vs 43.1 mm on VAS, p=0.005) and discomfort (30.0 vs 51.4 mm, p=0.004) 2.
A double-blind RCT of 206 patients found that intranasal lidocaine spray was safe and effective in reducing patient discomfort and difficulty of NG tube insertion compared to placebo 3.
Recommended Application Technique
Use 10% lidocaine spray to the nostril and throat, followed by 2% lidocaine jelly lubrication on the NG tube itself 2. This combination approach provides:
- Superior pain control during tube passage
- Higher patient satisfaction (93% vs 65% favoring the same method for future insertions, p=0.009)
- Greater physician satisfaction (p=0.041)
- No increase in complications, difficulty, or number of insertion attempts 2
Alternative Formulations
If 10% spray is unavailable, 4% atomized lidocaine (1.5 mL) or 2% lidocaine gel (5 mL) are acceptable alternatives, though patient preference studies suggest 2% lidocaine gel provides better global discomfort scores (p=0.017) 4.
Safety Considerations and Dosing
Maximum Safe Doses
When using topical lidocaine for NG tube insertion, remain well below toxic thresholds:
- For adults: maximum 4.5 mg/kg without epinephrine or 7.0 mg/kg with epinephrine 5
- For children: maximum 1.5-2.0 mg/kg without epinephrine or 3.0-4.5 mg/kg with epinephrine 5, 6, 5
- Recent bronchoscopy guidelines suggest topical doses should not exceed 9 mg/kg lean body weight, though lower concentrations (1%) are as effective as higher concentrations (2%) and are safer 7
Important Caveats
- Use the lowest effective dose to minimize risk of systemic toxicity 5
- Avoid application on cut, irritated, or swollen nasal mucosa 8
- Exercise increased caution in special populations including pediatric patients, those with congestive heart failure, or liver dysfunction due to increased risk of cardiac toxicity and impaired metabolism 7
- Monitor for early signs of local anesthetic systemic toxicity (LAST): circumoral numbness, facial tingling, metallic taste, dizziness, or euphoria 5
Contraindications
Do not use lidocaine spray in patients with:
- True lidocaine allergy (consider ester-type anesthetics, diphenhydramine 1%, or bacteriostatic saline as alternatives) 5
- Uncontrolled epilepsy or those using class III antiarrhythmic agents 9
Clinical Outcomes
The use of lidocaine for NG tube insertion does not compromise procedural success:
- No significant difference in difficulty of insertion (MD -0.30, p=0.55), number of attempts (MD -0.22, p=0.56), or success rates 1
- No increase in adverse events including nasal bleeding (OR 0.62, p=0.59) or vomiting (OR 0.30, p=0.10) 1
Practical Implementation
Apply lidocaine spray 30-40 minutes before the procedure for optimal anesthetic effect, though some formulations may work more rapidly 10. The combination of spray to mucosa plus gel lubrication on the tube provides the most comprehensive anesthesia coverage for the entire insertion pathway 2.